The role of molecular pathways in therapeutic response and outcomes in breast cancer
The role of molecular pathways in therapeutic response and outcomes in breast cancer
The revolution in personalised healthcare: Towards improved outcomes in oncology: Conclusion and Summary
Development of biosimilars for use in treating elderly patients
Evaluating and screening geriatric patients for treatment
Clinical trials, ENGOT and use of bevacizumab against angiogenesis
Overview of the 2013 ESGO scientific programme
Understanding the causes of endometrial cancer
Molecular profiling of primary compared to metastatic lesion in gynaecologic cancers
European Cancer Congress 2013 - News Roundup
Meeting highlights from the 11th iwNHL 2013: Day 1
Evaluation of FIRE3 trial and ASPECT study in mCRC; implications in Japan
FIRE-3 trial: Analysis of KRAS/NRAS and BRAF mutations and the potential for biomarkers